Literature DB >> 9813790

Relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias.

J L Payne1, C G Lyketsos, C Steele, L Baker, E Galik, S Kopunek, M Steinberg, A Warren.   

Abstract

Patients with clinical diagnoses of Alzheimer's disease, vascular dementia, or undifferentiated dementia were rated on standardized measures of depression, cognitive impairment, and functional impairment. Logistic regression was used to evaluate the relationship between functional or cognitive impairment, as well as their interaction, and depressive features in each group. This analysis revealed notable differences by type of dementia. The results imply that the mechanisms underlying depression in Alzheimer's disease may be different from those in vascular and other types of dementia. These results also provide indicators to the clinician for further evaluation of depression in different dementia subtypes.

Entities:  

Mesh:

Year:  1998        PMID: 9813790     DOI: 10.1176/jnp.10.4.440

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  11 in total

1.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

2.  Psychiatric disorders and cognitive dysfunction among older, postmenopausal women: results from the Women's Health Initiative Memory Study.

Authors:  Christopher C Colenda; Claudine Legault; Stephen R Rapp; Margaret W DeBon; Patricia Hogan; Robert Wallace; Linda Hershey; Judith Ockene; Rachael Whitmer; Lawrence S Phillips; Gloria E Sarto
Journal:  Am J Geriatr Psychiatry       Date:  2010-02       Impact factor: 4.105

3.  Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression.

Authors:  V Bhagya; B N Srikumar; T R Raju; B S Shankaranarayana Rao
Journal:  Psychopharmacology (Berl)       Date:  2010-11-04       Impact factor: 4.530

Review 4.  The role of depression severity in the cognitive functioning of elderly subjects with central nervous system disease.

Authors:  R van Reekum; M Simard; D Clarke; D Conn; T Cohen; J Wong
Journal:  J Psychiatry Neurosci       Date:  2000-05       Impact factor: 6.186

5.  APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies.

Authors:  Mathew Niti; Keng-Bee Yap; Ee-Heok Kua; Tze-Pin Ng
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-30       Impact factor: 6.053

6.  Influences of lobar gray matter and white matter lesion load on cognition and mood.

Authors:  Susanne G Mueller; Wendy J Mack; Dan Mungas; Joel H Kramer; Valerie Cardenas-Nicolson; Helen Lavretsky; Maxwell Greene; Norbert Schuff; Helena C Chui; Michael W Weiner
Journal:  Psychiatry Res       Date:  2010-01-13       Impact factor: 3.222

7.  Behavioral disturbances in dementia.

Authors:  Franz Müller-Spahn
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

8.  The human disease network in terms of dysfunctional regulatory mechanisms.

Authors:  Jing Yang; Su-Juan Wu; Wen-Tao Dai; Yi-Xue Li; Yuan-Yuan Li
Journal:  Biol Direct       Date:  2015-10-08       Impact factor: 4.540

9.  Modulation of GSK-3β/β-Catenin Signaling Contributes to Learning and Memory Impairment in a Rat Model of Depression.

Authors:  Jiaojie Hui; Jianping Zhang; Mengjia Pu; Xingliang Zhou; Liang Dong; Xuqiang Mao; Guofeng Shi; Jian Zou; Jingjing Wu; Dongmei Jiang; Guangjun Xi
Journal:  Int J Neuropsychopharmacol       Date:  2018-09-01       Impact factor: 5.176

Review 10.  Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.

Authors:  Jennifer Y Y Szeto; Simon J G Lewis
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.